Gameto has raised a $20 million Series A led by Future Ventures, PitchBook reports. The New York-based company is developing ovarian therapeutics intended to improve fertility and help women manage the impact of menopause. Additional investors included Bold Capital Partners, Lux Capital, Overwater Ventures, Plum Alley Investments, TA Ventures. Read more.
Related Posts
Sonendo Plans $133M IPO
General Atlantic, OrbiMed, Meritech Capital, and EW Healthcare Partners back the firm.
October 25, 2021
CareTrack Health Secures $2.5M From Hybrid Capital Partners
This funding followed 24% growth year-over-year, the company said.
August 3, 2022
Former Starbucks Exec, White House Official Engskov to Lead Home Health Care Startup
The startup is funded by ARCH Venture Partners, a venture capital firm that backs “disruptive science.”
October 4, 2021
Sena Health Secures Investment from Regal Healthcare Capital Partners
Founded in 2020, Sena Health partners with hospitals, payers, and medical groups to enable hospital-level care in patients' homes.
January 12, 2023